CVR: 26190770
Secondary names: Faaborg Løve Produkter A/S, Nordic Pharmacy A/S, ApoDerma A/S
DKK 13,336,305
Gross profit
Net result: DKK 747,032
Faaborg Løve Produkter Holding I ApS
CVR · view ownership and management
Owner registered: Faaborg Løve Produkter Holding I ApS
CVR · 15/12/2022
View the full event history
FAABORG PHARMA A/S is a Danish company of the type Aktieselskab based in Faaborg, founded in 2001. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Frank Hauken Vibæk. The company is owned by Faaborg Løve Produkter Holding I ApS. The company has 10 employees (2018). In 2025, the company reported a gross profit of DKK 13,336,305 and a net result of DKK 747,032 compared with DKK 1,762,826 the year before. Equity in the 2025 report amounted to DKK 10,503,744.
Source: annual report 2025, Danish Business Authority
FAABORG PHARMA A/S demonstrates a positive trajectory in profitability, with gross profit increasing from 6,979,843 DKK in 2021 to 13,336,305 DKK in 2025, alongside a rise in net profit from 31,438 DKK to 747,032 DKK over the same period. The company has shown consistent growth in equity, reaching 10,503,744 DKK in 2025, indicating a strengthening financial position. However, the absence of revenue figures limits a comprehensive assessment of overall performance. With a focus on manufacturing personal care products, FAABORG PHARMA is positioned to leverage its growing profitability and equity to enhance its market presence in the industry.
AI-generated summary · Generated 14/08/2026
Selskabets formål er fabrikation og handel samt anden hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 13.3 mio. | 747 t. | 18.9 mio. | 10.5 mio. | 15 | |
| 202401/01/2024 – 31/12/2024 | 10.9 mio. | 1.8 mio. | 22.8 mio. | 9.8 mio. | 14 | |
| 202301/01/2023 – 31/12/2023 | 10.6 mio. | 1.6 mio. | 18.3 mio. | 8 mio. | 16 | |
| 202201/01/2022 – 31/12/2022 | 10.3 mio. | 1.6 mio. | 18.3 mio. | 6.4 mio. | 17 | |
| 202101/01/2021 – 31/12/2021 | 7 mio. | 31 t. | 14.7 mio. | 4.8 mio. | 15 | |
| 202001/01/2020 – 31/12/2020 | 11.3 mio. | 4 mio. | 14.4 mio. | 4.8 mio. | 11 | |
| 201901/01/2019 – 31/12/2019 | 6.5 mio. | 713 t. | 10.4 mio. | 801 t. | 11 | |
| 201801/01/2018 – 31/12/2018 | 6.8 mio. | 2.1 mio. | 8.2 mio. | 88 t. | 9 | |
| 201701/01/2017 – 31/12/2017 | 4.6 mio. | 510 t. | 7.4 mio. | -2 mio. | 8 | |
| 201601/01/2016 – 31/12/2016 | 5.4 mio. | 1.2 mio. | 7.1 mio. | -2.5 mio. | 7 | |
| 201501/01/2015 – 31/12/2015 | 2 mio. | -1.4 mio. | 7.2 mio. | -3.8 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 4.3 mio. | 478 t. | 7.2 mio. | -2.4 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 2.9 mio. | -1.7 mio. | 6.9 mio. | -2.9 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 2.8 mio. | -1.7 mio. | 5.7 mio. | -1.1 mio. | - |
Compared to 86 companies in Fremstilling af parfume, hårshampoo, tandpasta mv.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorFAABORG PHARMA A/S was founded on 15 August 2001.
FAABORG PHARMA A/S is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv. (industry code 204200).
FAABORG PHARMA A/S had 10 employees in 2018 according to the Danish CVR register.
FAABORG PHARMA A/S is owned by Faaborg Løve Produkter Holding I ApS.
faaborgpharma.dk belongs to FAABORG PHARMA A/S, CVR number 26190770.
In 2025, FAABORG PHARMA A/S reported a gross profit of DKK 13,336,305.
Claim this page to add your logo and social links. Free to get started.
FAABORG PHARMA A/S has published its annual report for 2025. Gross profit came to DKK 13,336,305, and the net result was DKK 747,032.
FAABORG PHARMA A/S has published its annual report for 2024. Gross profit came to DKK 10,879,561, and the net result was DKK 1,762,826.
FAABORG PHARMA A/S has published its annual report for 2023. Gross profit came to DKK 10,602,413, and the net result was DKK 1,610,649.
As of August 21, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FAABORG PHARMA A/S.
As of August 21, 2023, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2022. Gross profit came to DKK 10,327,505, and the net result was DKK 1,558,886.
As of December 15, 2022, Faaborg Løve Produkter Holding I ApS is registered as an owner of FAABORG PHARMA A/S with an ownership share of 100%.
As of December 1, 2022, Frank Hauken Vibæk is registered as director of FAABORG PHARMA A/S.
As of December 1, 2022, Sten Grønved Nielsen has stepped down as director of FAABORG PHARMA A/S.
As of October 21, 2022, Birk Simon Maldonado Andersen has joined the board of directors of FAABORG PHARMA A/S.
As of October 21, 2022, Sten Grønved Nielsen has left the board of directors of FAABORG PHARMA A/S.
As of October 21, 2022, Pernille Rosager Nielsen has left the board of directors of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2021. Gross profit came to DKK 6,979,843, and the net result was DKK 31,438.
FAABORG PHARMA A/S has published its annual report for 2020. Gross profit came to DKK 11,292,076, and the net result was DKK 3,991,734.
As of May 15, 2020, Jan Knudsen has joined the board of directors of FAABORG PHARMA A/S.
As of May 15, 2020, Jonas Rössing has left the board of directors of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2019. Gross profit came to DKK 6,457,078, and the net result was DKK 713,320.
FAABORG PHARMA A/S has published its annual report for 2018. Gross profit came to DKK 6,798,336, and the net result was DKK 2,113,676.
As of July 4, 2018, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of FAABORG PHARMA A/S.
As of July 4, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2017. Gross profit came to DKK 4,569,184, and the net result was DKK 509,762.
As of March 16, 2018, Pernille Rosager Nielsen has joined the board of directors of FAABORG PHARMA A/S.
As of December 20, 2017, Jonas Rössing has joined the board of directors of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2016. Gross profit came to DKK 5,352,132, and the net result was DKK 1,242,286.
As of April 5, 2016, Sten Grønved Nielsen has joined the board of directors of FAABORG PHARMA A/S.
As of April 5, 2016, Claus Wædeled has joined the board of directors of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 4,268,776, and the net result was DKK 478,081.
As of August 1, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FAABORG PHARMA A/S.
As of August 1, 2014, RATH & KNUDSEN STATSAUTORISEREDE REVISORER AKTIESELSKAB has stepped down as auditor of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2013. Gross profit came to DKK 2,864,028, and the net result was DKK -1,725,003.
FAABORG PHARMA A/S has published its annual report for 2012. Gross profit came to DKK 2,847,896, and the net result was DKK -1,654,394.
As of August 6, 2012, Sten Grønved Nielsen has left the board of directors of FAABORG PHARMA A/S.
As of August 6, 2012, Pernille Rosager Nielsen has left the board of directors of FAABORG PHARMA A/S.
As of August 6, 2012, Birthe Susanne Bisgaard has left the board of directors of FAABORG PHARMA A/S.
As of May 7, 2010, Sten Grønved Nielsen has joined the board of directors of FAABORG PHARMA A/S.
As of May 7, 2010, Pernille Rosager Nielsen has joined the board of directors of FAABORG PHARMA A/S.
As of May 7, 2010, Birthe Susanne Bisgaard has joined the board of directors of FAABORG PHARMA A/S.
As of May 11, 2009, RATH & KNUDSEN STATSAUTORISEREDE REVISORER AKTIESELSKAB has been appointed auditor of FAABORG PHARMA A/S.
As of May 11, 2009, Revisionsfirmaet Rath & Knudsen has stepped down as auditor of FAABORG PHARMA A/S.
As of August 15, 2001, Revisionsfirmaet Rath & Knudsen has been appointed auditor of FAABORG PHARMA A/S.
As of August 15, 2001, Sten Grønved Nielsen is registered as director of FAABORG PHARMA A/S.
FAABORG PHARMA A/S was founded on August 15, 2001.
Companies in the same industry and area
